Follow RSS for latest reports on this topicPulmonary Hypertension - Market Research and Reports

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of affected individuals. Symptoms can range from mild breathlessness and fatigue during normal daily activity to heart failure, severe reduction in exercise capacity and reduced life expectancy. PAH is one group within the classification of pulmonary hypertension (PH), responsible for approximately 260,000 hospital visits and 16,000 deaths in the U.S. each year.

Pulmonary hypertension is a potentially serious health condition that can lead to heart failure.

Symptoms of pulmonary hypertension include:

  • shortness of breath
  • fatigue (extreme tiredness)
  • dizziness
  • feeling faint
  • chest pain (angina)
  • a racing heartbeat (tachycardia)
  • leg swelling

Your symptoms may get worse when you exercise, which can limit your ability to take part in physical activities.

Twitter - https://twitter.com/HypertensionBio

Keywords

Pulmonary Hypertension, PAH, Pulmonary arterial hypertension, hypertension

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country): Opportunities and Forecasts (2016-2021) - (By Drug Class -Endothelin Receptor Antagonists, Prostacyclin & Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others; By Region-North America, Europe, APAC, Latin America, MEA; By Country- USA, Canada, UK, Germany, Japan, Brazil, South Africa) [Report Updated: 01-08-2016]

Executive SummaryA comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of the global Pulmonary Arterial Hypertension (PAH) market on the basis of Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V Inhibitors, ...Read More >>>

Published:
2016-08-01

Published by: Azoth Analytics

Prices Starting From:
$2400

Additional Searches

You may also like to search separately for: Pulmonary Hypertension

We Stock...

{STICKYFOOTERMOBILE}